These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25397621)

  • 21. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis].
    Urso S; Pacciani E; Fariello G; Colajacomo M; Fassari FM; Randisi F; Certo A; Liberatore M; Pagnotta G
    Radiol Med; 1995 Sep; 90(3):212-8. PubMed ID: 7501824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiological premises to radiotracers for bone metastases.
    Cuccurullo V; Cascini G; Rossi A; Tamburrini O; Rotondo A; Mansi L
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):353-73. PubMed ID: 21738112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
    Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
    J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results.
    Morris PG; Poznak CV; Modi S; Mak AF; Patil S; Larson S; Hudis CA; Divgi C; Grewal RK
    Clin Breast Cancer; 2010 Feb; 10(1):33-9. PubMed ID: 20133256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical spectrum of asymptomatic femoral neck abnormal uptake on bone scintigraphy.
    Sopov V; Fuchs D; Bar-Meir E; Gorenberg M; Groshar D
    J Nucl Med; 2002 Apr; 43(4):484-6. PubMed ID: 11937591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technetium-99m-MDP scintigraphy and long-term follow-up of treated primary malignant bone tumors.
    Van Laere K; Casier K; Uyttendaele D; Mondelaers W; De Sadeleer C; Simons M; Dierckx R
    J Nucl Med; 1998 Sep; 39(9):1563-9. PubMed ID: 9744344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
    Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
    Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone scintigraphy in stomatology].
    Reychler H
    Acta Stomatol Belg; 1982; 79(4):291-302. PubMed ID: 6220585
    [No Abstract]   [Full Text] [Related]  

  • 34. Timing and optimized acquisition parameters for the whole-body imaging of ¹⁷⁷Lu-EDTMP toward performing bone pain palliation treatment.
    Liu C; Brašić JR; Liu X; Li H; Xiang X; Luo Z; Wang Y; Kuai D; Zhang G; Zaknun JJ
    Nucl Med Commun; 2012 Jan; 33(1):90-6. PubMed ID: 22001721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
    Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
    Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
    Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nuclear medicine imaging in recognizing different causes of osteonecrosis of the jaw.
    Joshi JK; Kushner GM; Bhatt G; Bhatt AD; Civelek AC
    Clin Nucl Med; 2013 Jan; 38(1):40-3. PubMed ID: 23242045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
    Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
    Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.